A Review of Best Practices for Intravenous Push Medication Administration

Janelle R Lenz¹, Daniel D Degnan, John B Hertig+1

• ¹Eli Lilly and Company (Dr Lenz), Purdue University College of Pharmacy (Drs Degnan and Hertig), University of Michigan College of Pharmacy (Dr Stevenson), and Visante, Inc (Dr Stevenson). Janelle R. Lenz, PharmD, is internal liaison at Eli Lilly and Company, supporting field-based medical liaisons within the areas of neurodegeneration and pain. At the time of writing this article, Dr Lenz was completing a medication safety fellowship with the Purdue College of Pharmacy and Lilly. Daniel D. Degnan, PharmD, MS, CPPS, FASHP, is the senior project manager at the Center for Medication Safety Advancement at Purdue University College of Pharmacy. Previously, he spent 10 years as the medication safety officer at a large health system in Indiana. John B. Hertig, PharmD, MS, CPPS, is the associate director at the Center for Medication Safety Advancement at the Purdue University College of Pharmacy. He has professional interests in pharmacy practice health policy. He currently serves as a contributing editor for several quality and safety publications. James G. Stevenson, PharmD, FASHP, is a professor in the department of clinical pharmacy at the University of Michigan College of Pharmacy. He is also president of Visante, Inc, a medicines management consulting company. He served as chief pharmacy officer for the University of Michigan Health System for 15 years.